Jump to content

Covid-19 vaccines thread


Duda Jarek

Recommended Posts

7 minutes ago, studiot said:

As to whether the Pfizer vaccine is dead virus or fragments of virus is a bit of a pointless argument.

If I gut and fillet a dead fish for the table, it is still a dead fish (but with bits missing).
If I hold a hog roast the thing turing on the spit over the firepit in the garden is still a dead pig (but with bits missing).

But if I put a  loin joint of pork in the oven, that is fragment of pig.

I understand the difference between the Pfizer and Oxford vaccines are the difference between my fish or hog roast and sticking the legs off a pig onto a turkey.

Actually no, the mechanism to how they are generated are so vastly different that it has severe impact on their effect and production. In short a RNA vaccine holds the promise of rapid vaccine development. Once you sequenced a virus you could just identify an unique stretch, synthesize it and put it into a lipid shell. 

An attenuated vaccine requires to cultivate and purify the virus, inactivate them in a way to render them harmless but still retain immunogenicity (which is tricky and takes a long time). Using parts of the virus requires again a genetic step but then you still have to express the protein in vivo or in vitro, purify it and then use the resulting product as a vaccine.

Think about it that way, instead of raising a pork and roasting it, or even just cut off pieces of it (which is actually not a a good example, it is more like raising just a leg instead of a whole pork) you just take a picture of a hog, and then use the digitized information to print out something that you can just eat (yes, stupid analogy, but it is that different).

All antigen production happen within your body now, instead of requiring to produce them.

Link to comment
Share on other sites

3 minutes ago, CharonY said:

Actually no, the mechanism to how they are generated are so vastly different that it has severe impact on their effect and production. In short a RNA vaccine holds the promise of rapid vaccine development. Once you sequenced a virus you could just identify an unique stretch, synthesize it and put it into a lipid shell. 

An attenuated vaccine requires to cultivate and purify the virus, inactivate them in a way to render them harmelss but still retain immunogenicity (which is tricky and takes a long time). Using parts of the virus requires again a genetic step but then you still have to express the protein in vivo or in vitro, purify it and then use the resulting product as a vaccine.

Think about it that way, instead of raising a pork and roasting it, or even just cut off pieces of it (which is actually not a a good example, it is more like raising just a leg instead of a whole pork) you just take a picture of a hog, and then use the digitized information to print out something that you can just eat (yes, stupid analogy, but it is that different).

All antigen production happen within your body now, instead of requiring to produce them.

A useful and effective analogy. I am now better informed. Thank you.

Link to comment
Share on other sites

  • 2 weeks later...

Tomorrow EU starts mass vaccination https://www.france24.com/en/europe/20201226-european-union-begins-coronavirus-vaccine-rollout-as-new-strain-spreads ... as the new strains like UK's are quickly spreading - what do we know about vaccine efficiency for them?

It is great that there are lots of them - covering various mechanisms, hopefully allowing for effective war with mutations (https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html 3 approved, 5 limited approved, 18 in phase III).

 

Very nice explanation of Pfizer mRNA vaccine: https://berthub.eu/articles/posts/reverse-engineering-source-code-of-the-biontech-pfizer-vaccine/, especially:

- it uses Psi (1-methyl-3’-pseudouridylyl) instead of U (uracil) - works the same, but with weaker immune response,

- uses synonymous codons with increased numbers of C and Gs (e.g. CUU -> CUG both encode Leucine), which are converted more efficiently into proteins,

- two amino acids are changed comparing to virus spike protein (K,V -> P) to handle the problem of difference between pre- and post-fusion spike protein - this exchange into Proline makes them fold into the proper shape without being mounted to a virus (known since 2017 thanks to work on SARS-CoV-1).

Link to comment
Share on other sites

  • 2 weeks later...
On 12/26/2020 at 10:08 AM, Duda Jarek said:

as the new strains like UK's are quickly spreading - what do we know about vaccine efficiency for them?

Obviously many are coming, naturally selected especially for faster spread, now e.g. also from South Africa: https://www.cnbc.com/2021/01/06/south-africa-covid-strain-a-guide-to-what-you-need-to-know.html

Again good interview:

 

Edited by Duda Jarek
Link to comment
Share on other sites

  • 4 months later...

I'm in no position to evaluate the veracity of this article but it seems to indicate that the MMR vaccine may be responsible for lessening the impact of COVID-19 on people. In part, the more recent the MMR vaccination, the less likely you are to have a severe reaction to the disease. Hence, younger people are impacted by COVID-19 less than older people.

Quote

It has been theorized that the measles-mumps-rubella (MMR) vaccine may protect against or reduce the severity of coronavirus disease 2019 (COVID-19) infection (15). Gold et al. introduced this theory in March 2020 after observing that recent, large-scale MMR vaccination campaigns were associated with countries with the fewest COVID-19 deaths (6).

https://mbio.asm.org/content/11/6/e02628-20

Link to comment
Share on other sites

I only glanced through it so may have missed some dinner points. It seems interesting, but considering the end points measured, the cohort is too small and needs to be much more age stratified. Titer and disease severity correlate with age.

Link to comment
Share on other sites

  • 1 month later...

Some pretty nice evidence that history of MMR or Tdap vaccination yields better outcomes in patients infected with COVID with T-cell mediated protection:

"Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens"

https://www.biorxiv.org/content/10.1101/2021.05.03.441323v1

https://www.alviss.ai/fullpage/2356220/3

The study has enough power and propensity matching seems to have worked. I would have appreciated p-values in the table 2 though.

 

Link to comment
Share on other sites

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.